Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $18.45 USD
Change Today +0.82 / 4.65%
Volume 156.2K
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jay M. Moyes MBA

Independent Director, Chairman of Audit Committee and Member of Nominating Committee,Osiris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 4 different organizations across 7 different industries.

See Board Relationships


Mr. Jay M. Moyes, MBA served as the Chief Financial Officer at Amedica Corporation from October 2013 to August 7, 2014 and served as its Principal Accounting Officer until August 7, 2014. Mr. Moyes served as Chief Financial Officer of XDx, Inc. since May 2008. Mr. Moyes served as the Chief Financial Officer and Treasurer of Myriad Genetics Inc., from June 1996 to November 1, 2007 and served as its Principal Accounting Officer and Assistant Secretary until November 1, ...

Read Full Background

Corporate Headquarters*

7015 Albert Einstein Drive
Columbia, Maryland 21046

United States

Phone: 443-545-1800
Fax: 443-545-1701

Board Members Memberships*

Independent Director, Chairman of Audit Committee and Member of Nominating Committee
Director, Chairman of Compensation Committee and Member of Audit Committee
Independent Director
Director, Chairman of Compensation Committee, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee


The University of Utah
Weber State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$68,000
Total Calculated Compensation$68,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSIR:US $18.45 USD +0.82


Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Vericel Corporation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
James Patrick Mackin Chairman of the Board, Chief Executive Officer and President
CryoLife Inc.
Edward Joseph Quilty BA,MBAChairman, Chief Executive Officer and President
Derma Sciences Inc.
Thomas Axelsson M.Sc.Chief Executive Officer
Vitrolife AB (publ)
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSIRIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at